Premium
Reduced Baroreflex Function in the STZ‐Induced Rat Model of Alzheimer's Disease
Author(s) -
Ehlen John Christian,
Ostrowski Daniela,
Ostrowski Tim Daniel
Publication year - 2019
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2019.33.1_supplement.558.8
Subject(s) - baroreflex , medicine , blood pressure , streptozotocin , baroreceptor , splanchnic , endocrinology , ctl* , orthostatic vital signs , morris water navigation task , anesthesia , heart rate , hemodynamics , diabetes mellitus , hippocampal formation , antigen , cd8 , immunology
Background Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing multiple autonomic conditions including cardiovascular impairments. The inability to maintain blood pressure via baroreflex regulation is up to 5.6 times more prevalent in AD and patients present most commonly with orthostatic hypotension. This study aimed to assess the influence of AD on autonomic regulation of blood pressure using the streptozotocin (STZ)‐induced AD rat model, which mimics many hallmark symptoms of sporadic AD in humans. Methods Male Sprague‐Dawley rats (345 ± 18 g) were randomly divided into two groups and subjected to intracerebroventricular injection of either vehicle (citrate buffer, CTL) or 2 mg/kg STZ in citrate buffer. After two weeks, memory performance (Morris water maze, MWM), baroreflex function (via femoral cannulation), and heart rate variability (HRV) were evaluated. Results MWM verified memory impairment in STZ‐treated rats when compared to CTL (p≤0.01). Analysis of baroreflex function in anesthetized rats revealed a significant impairment in the STZ group when compared to CTL. Particularly, STZ‐treated rats were unable to increase compensatory HR at lower blood pressures (at 50 mmHg: CTL, n=5, 369 ± 13 bpm vs. STZ, n=7, 315 ± 14 bpm; p≤0.05). STZ rats also had a lower baroreflex gain indicating reduced sensitivity to blood pressure fluctuations (p≤0.001). Additionally, recordings of splanchnic sympathetic nerve activity (SSNA) in a subset of rats identified reduced nerve activity during low blood pressure in the STZ group (∫SSNA at 50 mmHg: CTL, n=3, 0.3 ± 0.03 mV.s vs. STZ, n=3, 0.17 ± 0.02 mV.s; p≤0.05). There was no difference between groups at higher blood pressures (150 mmHg). Within the STZ group, HRV was significantly increased only during PE infusion (SDNN, p≤0.05; SD1, p≤0.05; SD2, p≤0.05). Interestingly, the change in HR following blockage of sympathetic or parasympathetic input was not different between groups. Also intrinsic HR and the blood pressure change to ganglionic blockage were similar between STZ and CTL rats. Conclusions Our study provides the first insight into the pathological influence of AD on baroreflex function. We showed that STZ rats exhibit lower HR and reduced sympathetic output in response to low blood pressure. These results provide the basis for identifying the mechanism behind orthostatic hypotension in AD patients. Support or Funding Information ATSU biomedical grant (JCE) and seed money (TDO) This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .